A strategy for enhancing the transcriptional activity of weak cell type-specific promoters

Gene Therapy

Volumn 5, Issue 12, 1998, Pages 1656-1664

  Nettelbeck, D M ^a   Jerome V ^a   Muller R ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Endothelial cell specific transcription; Gastrointestinal specific transcription; Sucrase isomaltase promoter; Tissue specific promoters; Transcriptional targeting; Von Willebrand factor promoter

Indexed keywords

ETOPOSIDE; SUCRASE ISOMALTASE; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR; VON WILLEBRAND FACTOR;

ANIMAL CELL; ARTICLE; CELL SPECIFICITY; CLONING VECTOR; GENE THERAPY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NONHUMAN; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; TISSUE SPECIFICITY;

ANIMALIA;

EID: 0032445097     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300778     Document Type: Article

References (12)

1. Sikora K. Gene therapy for cancer. Trends Biotech 1993; 11: 197-201.
2. Miller N, Vile RG. Targeted vectors for gene therapy. FASEB J 1995; 9: 190-199.
3. Miller N, Whelan J. Progress in transcriptionally targeted and regulatable vectors for genetic therapy. Hum Gene Ther 1997; 8: 803-815.
4. Vile RG, Hart IR. Use of tissue-specific expression of the herpes simplex virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection of DNA. Cancer Res 1993; 53: 3860-3863.
5. Vile RG, Hart IR. In vivo and in vitro targeting of gene expression to melanoma cells. Cancer Res 1993; 53: 962-967.
6. Siders WM, Halloran PJ, Fenton RG. Transcriptional targeting of recombinant adenoviruses to human and murine melanoma cells. Cancer Res 1996; 56: 5638-5646.
7. Arbuthnot PB et al. In vitro and in vivo hepatoma cell-specific expression of a gene transferred with an adenoviral vector. Hum Gene Ther 1996; 7: 1503-1514.
8. Chen L et al. Breast cancer selective gene expression and therapy mediated by recombinant adenoviruses containing the DF3/MUC1 promoter. J Clin Invest 1995; 96: 2775-2782.
9. Lee C-H, Liu M, Sie K-L, Lee M-S. Prostate-specific antigen driven gene therapy targeting DNA-polymerase a and topoisomerase IIa in prostate cancer. Anticancer Res 1996; 16: 1805-1812.
10. Abdallah B et al. A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: polyethylenimine. Hum Gene Ther 1996; 7: 1947-1954.
11. Dachs GU et al. Targeting gene expression to hypoxic tumor cells. Nature Med 1997; 3: 5515-5520.
12. Parr MJ el al. Tumor-selective expression in vivo mediated by an E2F-responsive adenoviral vector. Nature Med 1997; 3: 1145-1149.